Leavell Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$633K Buy
7,242
+195
+3% +$18.7K 0.03% 378
2025
Q4
$682K Buy
7,047
+199
+3% +$19.3K 0.03% 351
2025
Q3
$657K Buy
6,848
+1,335
+24% +$123K 0.03% 364
2025
Q2
$484K Buy
5,513
+103
+2% +$8.73K 0.02% 411
2025
Q1
$490K Buy
5,410
+79
+1% +$7.07K 0.02% 386
2024
Q4
$430K Buy
5,331
+226
+4% +$19.6K 0.02% 398
2024
Q3
$463K Sell
5,105
-70
-1% -$5.89K 0.02% 396
2024
Q2
$411K Buy
5,175
+351
+7% +$28.8K 0.02% 386
2024
Q1
$424K Sell
4,824
-692
-13% -$59.1K 0.02% 372
2023
Q4
$458K Buy
5,516
+242
+5% +$18.4K 0.03% 341
2023
Q3
$417K Buy
5,274
+219
+4% +$18.3K 0.03% 347
2023
Q2
$449K Sell
5,055
-475
-9% -$40.9K 0.03% 343
2023
Q1
$450K Buy
5,530
+63
+1% +$5.13K 0.03% 333
2022
Q4
$429K Sell
5,467
-263
-5% -$21.3K 0.03% 331
2022
Q3
$467K Buy
5,730
+984
+21% +$88.4K 0.04% 314
2022
Q2
$429K Buy
4,746
+75
+2% +$7.6K 0.03% 324
2022
Q1
$521K Sell
4,671
-380
-8% -$40.1K 0.04% 303
2021
Q4
$526K Sell
5,051
-1,656
-25% -$192K 0.04% 310
2021
Q3
$845K Buy
6,707
+1,272
+23% +$165K 0.06% 240
2021
Q2
$645K Hold
5,435
0.05% 261
2021
Q1
$645K Sell
5,435
-147
-3% -$17.2K 0.05% 261
2020
Q4
$657K Sell
5,582
-447
-7% -$49.2K 0.06% 249
2020
Q3
$630K Buy
6,029
+117
+2% +$11.8K 0.05% 240
2020
Q2
$546K Sell
5,912
-53
-0.9% -$5.08K 0.05% 245
2020
Q1
$541K Hold
5,965
0.06% 222
2019
Q4
$680K Buy
5,965
+867
+17% +$95.1K 0.06% 235
2019
Q3
$556K Buy
5,098
+94
+2% +$9.81K 0.06% 255
2019
Q2
$487K Hold
5,004
0.05% 266
2019
Q1
$458K Sell
5,004
-70
-1% -$6.26K 0.05% 267
2018
Q4
$464K Sell
5,074
-217
-4% -$20.3K 0.06% 243
2018
Q3
$523K Hold
5,291
0.06% 250
2018
Q2
$453K Hold
5,291
0.05% 263
2018
Q1
$427K Buy
5,291
+200
+4% +$16.5K 0.05% 273
2017
Q4
$411K Sell
5,091
-400
-7% -$32K 0.05% 284
2017
Q3
$427K Sell
5,491
-150
-3% -$12.5K 0.05% 267
2017
Q2
$501K Hold
5,641
0.06% 249
2017
Q1
$454K Buy
5,641
+536
+10% +$41.9K 0.06% 250
2016
Q4
$364K Sell
5,105
-27
-0.5% -$2.12K 0.05% 272
2016
Q3
$443K Buy
5,132
+75
+1% +$6.54K 0.07% 252
2016
Q2
$439K Buy
5,057
+600
+13% +$48.5K 0.06% 256
2016
Q1
$334K Sell
4,457
-700
-14% -$52.7K 0.05% 283
2015
Q4
$397K Sell
5,157
-100
-2% -$7.53K 0.06% 256
2015
Q3
$352K Sell
5,257
-4,245
-45% -$313K 0.06% 276
2015
Q2
$704K Hold
9,502
0.11% 194
2015
Q1
$741K Buy
9,502
+3,992
+72% +$303K 0.11% 195
2014
Q4
$398K Sell
5,510
-85
-2% -$5.91K 0.06% 279
2014
Q3
$347K Hold
5,595
0.06% 285
2014
Q2
$357K Hold
5,595
0.06% 279
2014
Q1
$344K Sell
5,595
-200
-3% -$11.7K 0.06% 279
2013
Q4
$333K Hold
5,795
0.06% 287
2013
Q3
$309K Hold
5,795
0.06% 290
2013
Q2
$298K Buy
+5,795
New +$286K 0.06% 287

Other funds holding MDT

Leavell Investment Management's MDT Position: Q1 2026 in Review

Leavell Investment Management increased its Medtronic (MDT) stake by 2.8% in Q1 2026, buying an estimated $18.7K and bringing the position to 7,242 shares worth $633K. The position accounts for 0.03% of the portfolio, ranked #378.

Leavell Investment Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $845K in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Leavell Investment Management held 7,242 shares of Medtronic worth $633K as of Q1 2026.
  • Leavell Investment Management bought 195 Medtronic shares in Q1 2026, an estimated $18.7K.
  • Medtronic made up 0.03% of Leavell Investment Management's portfolio in Q1 2026, its #378 holding.
  • Leavell Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Leavell Investment Management's Medtronic position peaked at $845K in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Leavell Investment Management's 13F filing for Q1 2026, filed 12 May 2026.